Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Return on Invested Capital (2023 - 2024)

Historic Return on Invested Capital for Voyager Therapeutics (VYGR) over the last 5 years, with Q3 2025 value amounting to 0.61%.

  • Voyager Therapeutics' Return on Invested Capital fell 6300.0% to 0.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61%, marking a year-over-year decrease of 6300.0%. This contributed to the annual value of 0.31% for FY2024, which is 11300.0% down from last year.
  • Per Voyager Therapeutics' latest filing, its Return on Invested Capital stood at 0.61% for Q3 2025, which was down 6300.0% from 0.48% recorded in Q2 2025.
  • Voyager Therapeutics' Return on Invested Capital's 5-year high stood at 0.67% during Q1 2023, with a 5-year trough of 0.61% in Q3 2025.
  • Over the past 3 years, Voyager Therapeutics' median Return on Invested Capital value was 0.02% (recorded in 2024), while the average stood at 0.01%.
  • Over the last 5 years, Voyager Therapeutics' Return on Invested Capital had its largest YoY gain of -2000bps in 2024, and its largest YoY loss of -8500bps in 2024.
  • Voyager Therapeutics' Return on Invested Capital (Quarter) stood at 0.59% in 2023, then plummeted by -146bps to 0.27% in 2024, then plummeted by -128bps to 0.61% in 2025.
  • Its Return on Invested Capital stands at 0.61% for Q3 2025, versus 0.48% for Q2 2025 and 0.36% for Q1 2025.